Helicobacter_NP pylori-Specific_JJ Immune_NP Responses_NNS of_IN Children_NNS :_: Implications_NNS for_IN Future_NP Vaccination_NP Strategy_NP We_PP analyzed_VBD the_DT specific_JJ anti-Helicobacter_NN pylori_NNS immunoglobulin_NN G_NP (_( IgG_NP )_) antibody_NN profile_NN for_IN a_DT sample_NN of_IN 824_CD asymptomatic_JJ schoolchildren_NNS in_IN southern_JJ Germany_NP (_( mean_JJ age_NN ,_, 10.7_CD +-_NN 0.65_CD years_NNS )_) with_IN an_DT H._NP pylori-specific_JJ IgG_NP enzyme-linked_JJ immunosorbent_JJ assay_NN and_CC Western_JJ blot_NN analysis_NN ._SENT The_DT prevalence_NN of_IN infection_NN was_VBD 19.8_CD %_NN (_( 95_CD %_NN confidence_NN interval_NN ,_, 17.1_CD to_TO 22.7_CD %_NN )_) ._SENT The_DT immunoresponses_NNS were_VBD characterized_VBN predominantly_RB by_IN antibodies_NNS against_IN low-molecular-mass_NN antigens_NNS of_IN 14_CD and_CC 29_CD kDa_NNS ,_, with_IN a_DT significant_JJ difference_NN between_IN children_NNS of_IN German_JJ and_CC Turkish_JJ nationalities_NNS (_( P_NN =_SYM 0.0012_CD and_CC P_NN <_SYM 0.0001_CD ,_, respectively_RB )_) ._SENT Helicobacter_NN pylori_NNS plays_VBZ an_DT etiologic_JJ role_NN in_IN gastritis_NN ,_, peptic_JJ ulcer_NN disease_NN ,_, gastric_JJ cancer_NN ,_, and_CC mucosa-associated_JJ lymphoid_JJ tissue_NN lymphoma_NN ,_, and_CC acquisition_NN of_IN the_DT infection_NN seems_VBZ to_TO occur_VB mainly_RB in_IN the_DT first_JJ years_NNS of_IN life_NN ._SENT Genetic_JJ typing_VBG has_VBZ shown_VBN that_IN H._NP pylori_NNS is_VBZ extremely_RB diverse_JJ as_IN a_DT species_NN and_CC possesses_VBZ a_DT number_NN of_IN antigens_NNS that_WDT induce_VBP a_DT specific_JJ immune_JJ response_NN in_IN infected_JJ individuals_NNS ._SENT The_DT specific_JJ immune_JJ response_NN is_VBZ part_NN of_IN the_DT natural_JJ history_NN of_IN the_DT infection_NN in_IN children_NNS ,_, which_WDT remains_VBZ poorly_RB characterized_VBN ,_, and_CC may_MD mirror_VB the_DT specific_JJ interaction_NN of_IN the_DT host_NN with_IN the_DT bacterium_NN (_( ,_, ,_, ,_, 21_CD )_) ._SENT This_DT immune_JJ response_NN may_MD be_VB of_IN special_JJ importance_NN with_IN regard_NN to_TO vaccination_NN ,_, as_IN it_PP may_MD determine_VB the_DT antigens_NNS considered_VBN for_IN a_DT vaccine_NN ._SENT However_RB ,_, the_DT few_JJ existing_JJ studies_NNS of_IN the_DT infection_NN in_IN children_NNS are_VBP based_VBN mainly_RB on_IN symptomatic_JJ and_CC small_JJ clinical_JJ samples_NNS ._SENT The_DT aim_NN of_IN this_DT study_NN was_VBD to_TO analyze_VB the_DT specific_JJ anti-H_NN ._SENT pylori_NNS immunoglobulin_NN G_NP (_( IgG_NP )_) antibody_NN profile_NN in_IN a_DT sample_NN of_IN asymptomatic_JJ schoolchildren_NNS ._SENT This_DT study_NN is_VBZ part_NN of_IN a_DT population-based_JJ investigation_NN performed_VBN by_IN the_DT Baden-Wurttemberg_NP State_NP Health_NP Office_NP between_IN October_NP 1999_CD and_CC April_NP 2000_CD with_IN a_DT sample_NN of_IN schoolchildren_NNS (_( fourth_JJ graders_NNS ;_: mean_VB age_NN +-_NN standard_JJ deviation_NN ,_, 10.7_CD +-_NN 0.65_CD years_NNS ;_: range_NN ,_, 9_CD to_TO 13_CD years_NNS ;_: median_JJ ,_, 11_CD years_NNS )_) living_VBG in_IN southern_JJ Germany_NP in_IN four_CD different_JJ areas_NNS of_IN Baden-Wurttemberg_NP (_( Stuttgart_NP ,_, Mannheim_NP ,_, Kehl_NP ,_, and_CC Ravensburg_NP )_) ._SENT Participation_NN in_IN the_DT study_NN was_VBD voluntary_JJ ._SENT The_DT study_NN was_VBD approved_VBN by_IN the_DT Ethics_NP Board_NP of_IN the_DT University_NP of_IN Ulm_NP ._SENT The_DT parents_NNS of_IN 1,118_CD children_NNS filled_VBN out_IN a_DT questionnaire_NN which_WDT requested_VBD information_NN regarding_VBG sociodemographic_JJ factors_NNS ,_, family_NN characteristics_NNS ,_, and_CC medical_JJ history_NN ._SENT Serum_NN samples_NNS from_IN 824_CD (_( 73.7_CD %_NN )_) of_IN those_DT 1,118_CD children_NNS were_VBD available_JJ ._SENT H._NP pylori_NNS IgG_NP antibodies_NNS were_VBD determined_VBN by_IN enzyme-linked_JJ immunosorbent_JJ assay_NN (_( GAP_NP ;_: Bio-Rad_NP Laboratories_NPS Diagnostics_NP Group_NP ,_, Munich_NP ,_, Germany_NP )_) ._SENT According_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ,_, levels_NNS of_IN >20_NP U/ml_NP were_VBD considered_VBN positive_JJ ._SENT This_DT test_NN has_VBZ previously_RB been_VBN evaluated_VBN with_IN 310_CD children_NNS (_( compared_VBN with_IN the_DT histology_NN ,_, culture_NN ,_, and_CC urease_NN test_NN ,_, the_DT sensitivity_NN of_IN our_PP$ test_NN was_VBD 94.9_CD %_NN and_CC the_DT specificity_NN was_VBD 92.4_CD %_NN )_) ._SENT The_DT serum_NN samples_NNS of_IN the_DT IgG-positive_NP children_NNS were_VBD further_RBR analyzed_VBN for_IN the_DT presence_NN of_IN antibodies_NNS against_IN H._NP pylori-specific_JJ antigens_NNS with_IN a_DT commercial_JJ Western_JJ blot_NN method_NN (_( Helicobacter_NP pylori_NNS Western_JJ blot_NN ;_: AID_NP ,_, Strasberg_NP ,_, Germany_NP )_) as_RB described_VBD previously_RB ._SENT Of_IN the_DT 824_CD children_NNS included_VBN in_IN the_DT study_NN ,_, 53.3_CD %_NN were_VBD boys_NNS ._SENT About_IN two-thirds_NNS ,_, or_CC 63.5_CD %_NN ,_, of_IN the_DT schoolchildren_NNS were_VBD of_IN German_JJ nationality_NN ,_, 12.5_CD %_NN were_VBD Turkish_JJ ,_, and_CC 12.7_CD %_NN were_VBD of_IN other_JJ nationalities_NNS (_( for_IN 89_CD of_IN the_DT children_NNS (_( 10.8_CD %_NN )_) ,_, there_EX were_VBD no_DT data_NN available_JJ concerning_VBG nationality_NN )_) ._SENT Information_NN gathered_VBD on_IN family_NN characteristics_NNS showed_VBD that_IN 10.2_CD %_NN of_IN the_DT children_NNS had_VBD no_DT siblings_NNS ,_, 43.3_CD %_NN had_VBD one_CD ,_, and_CC 38.1_CD %_NN had_VBD two_CD siblings_NNS ;_: 45.5_CD %_NN of_IN the_DT fathers_NNS and_CC 37.5_CD %_NN of_IN the_DT mothers_NNS had_VBD 9_CD or_CC fewer_JJR years_NNS of_IN school_NN education_NN ._SENT One_CD hundred_CD sixty-three_JJ children_NNS (_( 19.8_CD %_NN of_IN the_DT total_JJ number_NN ,_, 95_CD %_NN confidence_NN interval_NN [_SYM CI_NP ]_SYM ,_, 17.1_CD to_TO 22.7_CD %_NN )_) had_VBD positive_JJ serology_NN results_NNS for_IN H._NP pylori_NNS ._SENT The_DT seroprevalence_NN in_IN children_NNS of_IN German_JJ nationality_NN was_VBD 13.9_CD %_NN (_( 95_CD %_NN CI_NP ,_, 11.0_CD to_TO 17.1_CD %_NN )_) and_CC varied_VBN from_IN 12.4_CD %_NN (_( 95_CD %_NN CI_NP ,_, 9.6_CD to_TO 15.6_CD %_NN )_) for_IN the_DT German_JJ children_NNS born_VBN in_IN Germany_NP to_TO 42.3_CD %_NN (_( 95_CD %_NN CI_NP ,_, 23.4_CD to_TO 63.1_CD %_NN )_) for_IN the_DT German_JJ children_NNS born_VBN elsewhere_RB (_( mostly_RB children_NNS of_IN families_NNS who_WP had_VBD lived_VBN in_IN countries_NNS of_IN Eastern_NP Europe_NP for_IN generations_NNS and_CC who_WP had_VBD returned_VBN to_TO Germany_NP quite_RB recently_RB )_) ._SENT The_DT prevalence_NN of_IN H._NP pylori_NNS in_IN children_NNS of_IN Turkish_JJ nationality_NN was_VBD 37.9_CD %_NN (_( 95_CD %_NN CI_NP ,_, 28.5_CD to_TO 48.0_CD %_NN )_) (_( in_IN Turkish_JJ children_NNS ,_, place_NN of_IN birth_NN was_VBD not_RB associated_VBN with_IN seroprevalence_NN )_) ,_, and_CC for_IN children_NNS of_IN other_JJ nationalities_NNS ,_, it_PP was_VBD 30.5_CD %_NN (_( 95_CD %_NN CI_NP ,_, 21.9_CD to_TO 40.2_CD %_NN )_) ._SENT These_DT strong_JJ differences_NNS among_IN ethnic_JJ groups_NNS were_VBD independent_JJ of_IN socioeconomic_JJ factors_NNS ,_, such_JJ as_IN family_NN size_NN and_CC school_NN education_NN of_IN parents_NNS ,_, and_CC persisted_VBD after_IN these_DT factors_NNS had_VBD been_VBN controlled_VBN for_IN ._SENT On_IN the_DT other_JJ hand_NN ,_, duration_NN of_IN school_NN education_NN of_IN parents_NNS and_CC number_NN of_IN siblings_NNS were_VBD not_RB factors_NNS associated_VBN with_IN seroprevalence_NN if_IN ethnic_JJ origin_NN was_VBD considered_VBN in_IN the_DT analysis_NN (_( data_NNS not_RB shown_VBN )_) ._SENT TABLE_NN 1_CD |_SYM Prevalence_NN of_IN H._NP pylori_NNS infection_NN in_IN children_NNS according_VBG to_TO nationality_NN Western_JJ blots_NNS were_VBD used_VBN to_TO detect_VB and_CC analyze_VB eight_CD different_JJ H._NP pylori-specific_JJ immunoreactive_JJ bands_NNS ._SENT TABLE_NN 2_CD |_SYM Prevalence_NN of_IN specific_JJ H._NP pylori_NNS IgG_NP antibodies_NNS in_IN H._NP pylori-infected_JJ children_NNS (_( n_NN =_SYM 163_CD )_) Table_NP shows_VBZ that_IN antibodies_NNS to_TO the_DT 25-kDa_JJ antigen_NN and_CC the_DT 14-kDa_NP antigen_NN were_VBD detected_VBN much_RB more_RBR frequently_RB in_IN infected_JJ children_NNS of_IN Turkish_JJ or_CC other_JJ nationality_NN than_IN in_IN infected_JJ children_NNS of_IN German_JJ nationality_NN (_( P_NN values_NNS of_IN 0.0012_CD and_CC <0.0001_JJ ,_, respectively_RB )_) ._SENT TABLE_NN 3_CD |_SYM Prevalence_NN of_IN H._NP pylori-specific_JJ antibodies_NNS identified_VBN by_IN immunoblotting_VBG among_IN infected_JJ children_NNS according_VBG to_TO nationality_NN of_IN the_DT children_NNS (_( n_NN =_SYM 144_CD )_) This_DT study_NN ,_, conducted_VBN with_IN a_DT population-based_JJ sample_NN of_IN asymptomatic_JJ schoolchildren_NNS in_IN Germany_NP ,_, demonstrated_VBD that_IN the_DT specific_JJ systemic_JJ immune_JJ response_NN in_IN children_NNS to_TO H._NP pylori_NNS infection_NN is_VBZ particularly_RB pronounced_VBN against_IN low-molecular-weight_JJ proteins_NNS of_IN H._NP pylori_NNS ._SENT Furthermore_RB ,_, there_EX was_VBD a_DT large_JJ variation_NN in_IN both_CC the_DT prevalence_NN of_IN infection_NN and_CC the_DT specific_JJ antibody_NN patterns_NNS with_IN respect_NN to_TO the_DT nationalities_NNS of_IN the_DT children_NNS ,_, although_IN the_DT children_NNS were_VBD living_VBG in_IN the_DT same_JJ geographic_JJ region_NN ._SENT As_IN shown_VBN in_IN a_DT previous_JJ study_NN ,_, differences_NNS between_IN ethnic_JJ groups_NNS are_VBP not_RB explained_VBN by_IN differences_NNS in_IN socioeconomic_JJ factors_NNS and_CC most_RBS likely_JJ mirror_NN strain_NN differences_NNS among_IN these_DT groups_NNS ._SENT A_DT recent_JJ French_JJ study_NN of_IN 80_CD pediatric_JJ patients_NNS found_VBD the_DT highest_JJS prevalence_NN (_( 88.7_CD %_NN )_) for_IN antibodies_NNS to_TO a_DT 26-kDa_JJ antigen_NN ._SENT Little_RB is_VBZ known_VBN about_IN the_DT function_NN of_IN the_DT 26-kDa_JJ antigen_NN ,_, which_WDT may_MD be_VB identical_JJ to_TO the_DT 25-kDa_JJ antigen_NN in_IN our_PP$ study_NN ._SENT However_RB ,_, recently_RB it_PP has_VBZ been_VBN shown_VBN that_IN a_DT 25-kDa_JJ outer_JJ membrane_NN protein_NN acts_VBZ in_IN a_DT lectin-like_JJ manner_NN with_IN lipopolysaccharide_NN to_TO mediate_VB attachment_NN of_IN H._NP pylori_NNS to_TO laminin_NN and_CC may_MD therefore_RB be_VB important_JJ for_IN the_DT colonization_NN process_NN in_IN the_DT early_JJ phase_NN of_IN the_DT infection_NN ._SENT Much_JJ interest_NN exists_VBZ in_IN the_DT seroprevalence_NN in_IN children_NNS of_IN CagA_NP antibodies_NNS ,_, which_WDT ,_, according_VBG to_TO a_DT study_NN by_IN Mitchell_NP et_FW al._FW ,_, correlated_VBN with_IN age_NN and_CC increased_VBD up_RP to_TO the_DT age_NN of_IN 15_CD years_NNS ._SENT There_EX are_VBP few_JJ data_NNS available_JJ for_IN children_NNS ,_, and_CC the_DT results_NNS of_IN recent_JJ studies_NNS have_VBP been_VBN inconsistent_JJ concerning_VBG the_DT prevalence_NN and_CC association_NN with_IN disease_NN of_IN CagA-positive_JJ strains_NNS in_IN both_DT adults_NNS and_CC children_NNS (_( ,_, 6_CD ,_, ,_, ,_, ,_, ,_, )_) ._SENT This_DT may_MD be_VB due_JJ partly_RB to_TO the_DT considerable_JJ variation_NN in_IN the_DT frequencies_NNS of_IN vacAsl_NN subtypes_NNS and_CC iceA_NN alleles_NNS in_IN children_NNS originating_VBG from_IN different_JJ geographic_JJ regions_NNS ._SENT As_RB for_IN adults_NNS ,_, a_DT high_JJ prevalence_NN of_IN CagA-positive_NP H._NP pylori_NNS strains_NNS was_VBD found_VBN in_IN Japanese_JJ children_NNS ;_: however_RB ,_, there_EX was_VBD no_DT association_NN of_IN this_DT prevalence_NN with_IN nodular_JJ gastritis_NN or_CC peptic_JJ ulcer_NN disease_NN in_IN Japanese_JJ children_NNS (_( mean_JJ age_NN ,_, 12_CD +-_NN 3_CD years_NNS )_) ._SENT This_DT result_NN challenges_VBZ the_DT role_NN of_IN CagA_NP as_IN a_DT marker_NN for_IN more_JJR serious_JJ gastroduodenal_JJ disease_NN in_IN children_NNS as_IN well_RB as_RB in_IN adults_NNS in_IN Japan_NP ._SENT The_DT highest_JJS prevalence_NN of_IN CagA_NP antibodies_NNS in_IN Europe_NP (_( 80_CD %_NN )_) ,_, has_VBZ been_VBN found_VBN in_IN a_DT study_NN of_IN infected_JJ children_NNS in_IN Poland_NP ;_: the_DT prevalence_NN in_IN infected_JJ schoolchildren_NNS in_IN Estonia_NP (_( 9_CD to_TO 15_CD years_NNS old_JJ )_) was_VBD 46_CD %_NN ._SENT Raymond_NP et_FW al._FW described_VBD the_DT prevalence_NN of_IN CagA_NP antibodies_NNS in_IN children_NNS in_IN France_NP who_WP had_VBD abdominal_JJ pain_NN to_TO be_VB 43_CD %_NN ._SENT In_IN conclusion_NN ,_, the_DT differences_NNS in_IN the_DT antibody_NN patterns_NNS between_IN children_NNS of_IN various_JJ ethnic_JJ groups_NNS or_CC found_VBN in_IN our_PP$ study_NN may_MD indicate_VB strain_NN differences_NNS and_CC should_MD be_VB considered_VBN if_IN antigens_NNS are_VBP chosen_VBN as_IN targets_NNS for_IN a_DT vaccination_NN approach_NN ._SENT 